Takeda, Tomoya <br/><br/>
Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway.  [electronic resource] 

 -  International journal of oncology  Jun 2016 
 - 2704-12 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2016.3470  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Doxorubicin--pharmacology<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Melphalan--pharmacology<br/>Multiple Myeloma--drug therapy<br/>NF-kappa B--metabolism<br/>Signal Transduction--drug effects<br/>Vincristine--pharmacology<br/>Xanthones--pharmacology